Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration

BACKGROUND/AIMS: To study the initial characteristics and response to intravitreal ranibizumab (IVR) treatment of age-related macular degeneration (AMD). METHODS: We reviewed the clinical records of 141 eyes in 141 AMD patients who received monthly IVR for 3 months and thereafter pro re nata (PRN) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Misa, Nagai, Norihiro, Izumi-Nagai, Kanako, Shinoda, Hajime, Koto, Takashi, Uchida, Atsuro, Mochimaru, Hiroshi, Yuki, Kenya, Sasaki, Mariko, Tsubota, Kazuo, Ozawa, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145467/
https://www.ncbi.nlm.nih.gov/pubmed/24711658
http://dx.doi.org/10.1136/bjophthalmol-2013-304670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145467/
https://www.ncbi.nlm.nih.gov/pubmed/24711658
http://dx.doi.org/10.1136/bjophthalmol-2013-304670

Ejemplares similares